AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34172301 — intervention group
Group type: EXPERIMENTAL
Intervention: Original Sgarbossa Criteria
Number of subjects: 251
Study 34172301 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Sgarbossa Criteria (MSC) with concordant ST-depression in V4 to V6
Number of subjects: 251
Study 32682668 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil (5 mcg bolus 1 minute before larger dose)
Number of subjects: 220
Study 32682668 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (equal volume 1 minute before larger dose)
Number of subjects: 220
Study 34903568 — intervention group
Group type: EXPERIMENTAL
Intervention: Nudge-based letter intervention
Number of subjects: 4011
Study 34903568 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical letter intervention
Number of subjects: 4011
Study 34903568 — intervention group
Group type: COMPARATOR
Intervention: Control group (informed only of the screening results)
Number of subjects: 4011
Study 34903568 — intervention group
Group type: EXPERIMENTAL
Intervention: Nudge-based letter intervention and Clinical letter intervention
Number of subjects: 4011
Study 34376264 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroticism
Number of subjects: 109
Study 34376264 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraversion
Number of subjects: 109
Study 34376264 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroticism and Extraversion
Number of subjects: 109
Study 33285397 — intervention group
Group type: EXPERIMENTAL
Intervention: Informative titles
Number of subjects: 12
Study 33285397 — intervention group
Group type: COMPARATOR
Intervention: Generic titles
Number of subjects: 12
Study 33285397 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple graphs
Number of subjects: 12
Study 33285397 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex graphs
Number of subjects: 12
Study 33285397 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive results
Number of subjects: 12
Study 33285397 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative results
Number of subjects: 12
Study 33285397 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed results
Number of subjects: 12
Study 32402773 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold vapor application (group 1)
Number of subjects: 120
Study 32402773 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice cube absorption (group 2)
Number of subjects: 120
Study 32402773 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice cube absorption along with cold vapor application (group 3)
Number of subjects: 120
Study 32402773 — intervention group
Group type: COMPARATOR
Intervention: Control group (group 4)
Number of subjects: 120
Study 32402773 — intervention group
Group type: EXPERIMENTAL
Intervention: All application groups (group 1, 2, 3)
Number of subjects: 120
Study 32402773 — intervention group
Group type: EXPERIMENTAL
Intervention: Hoarseness incidence
Number of subjects: 120
Study 34864756 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam plus quetiapine
Number of subjects: 44
Study 34864756 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus quetiapine
Number of subjects: 44
Study 32561466 — intervention group
Group type: EXPERIMENTAL
Intervention: DM I‐TEAM (home-based multidisciplinary behavioral intervention)
Number of subjects: 200
Study 32561466 — intervention group
Group type: COMPARATOR
Intervention: Usual Medical Care (UMC)
Number of subjects: 200
Study 32561466 — intervention group
Group type: EXPERIMENTAL
Intervention: DM I‐TEAM
Number of subjects: 200
Study 36265504 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide 160 mg/day
Number of subjects: 271
Study 36265504 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 271
Study 34911609 — intervention group
Group type: EXPERIMENTAL
Intervention: Family rehabilitation treatment performed by parents under the guidance of professionals
Number of subjects: 60
Study 34911609 — intervention group
Group type: COMPARATOR
Intervention: Conventional group (online training on basic knowledge and rehabilitation training of ASD)
Number of subjects: 60
Study 33971995 — intervention group
Group type: EXPERIMENTAL
Intervention: Almond-enriched diet (AED)
Number of subjects: 124
Study 33971995 — intervention group
Group type: COMPARATOR
Intervention: Isoenergetic nut-free diet (NFD)
Number of subjects: 124
Study 34425788 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% inclined treadmill gait
Number of subjects: 24
Study 34425788 — intervention group
Group type: EXPERIMENTAL
Intervention: 16% inclined treadmill gait
Number of subjects: 24
Study 34425788 — intervention group
Group type: COMPARATOR
Intervention: Inclined treadmill walking (0%, 10%, 16%)
Number of subjects: 24
Study 34425788 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclined treadmill walking
Number of subjects: 24
Study 35466071 — intervention group
Group type: EXPERIMENTAL
Intervention: RIRS
Number of subjects: 138
Study 35466071 — intervention group
Group type: COMPARATOR
Intervention: SWL
Number of subjects: 138
Study 33844484 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 Hz iTBS of the left dorsolateral prefrontal cortex (dlPFC)
Number of subjects: 91
Study 33844484 — intervention group
Group type: COMPARATOR
Intervention: iTBS of the vertex (control)
Number of subjects: 91
Study 34559118 — intervention group
Group type: EXPERIMENTAL
Intervention: EZJDR (Erzhu Jiedu Recipe) administered twice a day after meals for 48 weeks
Number of subjects: 72
Study 34559118 — intervention group
Group type: COMPARATOR
Intervention: Placebo granules similar to EZJDR
Number of subjects: 72
Study 34915187 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganglionated plexuses ablation (GPA)
Number of subjects: 102
Study 34915187 — intervention group
Group type: COMPARATOR
Intervention: Pulmonary vein isolation (PVI)
Number of subjects: 102
Study 35194433 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (3 mg sublingual twice daily, then 9 mg single dose 30 min before apheresis session and then 3 mg twice daily from +1 until engraftment)
Number of subjects: 51
Study 35194433 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus Filgrastim
Number of subjects: 51
Study 36171519 — intervention group
Group type: EXPERIMENTAL
Intervention: 23.4% NaCl intravenous push
Number of subjects: 32
Study 33507958 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose corticosteroid pulse therapy (HDCPT) using at least 1.5mg/kg/24h of methylprednisolone or dexamethasone equivalent
Number of subjects: 318
Study 32780797 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Treatment (OMT), n=16
Number of subjects: 30
Study 32780797 — intervention group
Group type: COMPARATOR
Intervention: Concussion education counseling, n=14
Number of subjects: 30
Study 35142586 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Vaccine Education Program (VEP) videos
Number of subjects: 0
Study 35142586 — intervention group
Group type: COMPARATOR
Intervention: Science-based video unrelated to vaccines
Number of subjects: 0
Study 33099032 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide (human parathyroid hormone 1–34) for 18 months
Number of subjects: 0
Study 33099032 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35953535 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal intermittent positive pressure ventilation (NIPPV)
Number of subjects: 0
Study 35953535 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive high-frequency oscillatory ventilation (NHFO)
Number of subjects: 0
Study 35953535 — intervention group
Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure ventilation (NCPAP)
Number of subjects: 0
Study 33829482 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab
Number of subjects: 13518
Study 33829482 — intervention group
Group type: COMPARATOR
Intervention: Postmarketing surveillance data
Number of subjects: 13518
Study 33279809 — intervention group
Group type: EXPERIMENTAL
Intervention: Semantic intervention
Number of subjects: 20
Study 33279809 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonological intervention
Number of subjects: 20
Study 36344585 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on family-centered empowerment model (four 2-hour sessions and consulting support via social network and messaging service)
Number of subjects: 200
Study 36344585 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 200
Study 32278973 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicaid enrollees with orbital fractures
Number of subjects: 1541
Study 32278973 — intervention group
Group type: COMPARATOR
Intervention: Non-Medicaid enrollees
Number of subjects: 1541
Study 32278973 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicaid enrollees
Number of subjects: 1541
Study 32278973 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Medicaid and non-Medicaid)
Number of subjects: 1541
Study 34330219 — intervention group
Group type: EXPERIMENTAL
Intervention: VieScope
Number of subjects: 35
Study 34330219 — intervention group
Group type: COMPARATOR
Intervention: GlideScope
Number of subjects: 35
Study 34330219 — intervention group
Group type: COMPARATOR
Intervention: MAC
Number of subjects: 35
Study 32481487 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet group (MDG)
Number of subjects: 187
Study 32481487 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean lifestyle group (MLG)
Number of subjects: 187
Study 32481487 — intervention group
Group type: COMPARATOR
Intervention: Standard care group (SCG)
Number of subjects: 187
Study 36208720 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozanimod 0.92 mg daily for 12 weeks during induction
Number of subjects: 0
Study 36208720 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozanimod maintenance therapy for 52 weeks
Number of subjects: 0
Study 36208720 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks during induction
Number of subjects: 0
Study 36208720 — intervention group
Group type: COMPARATOR
Intervention: Placebo maintenance therapy for 52 weeks
Number of subjects: 0
Study 33039291 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous immunoglobulin (IgPro20) 0.2 g/kg bodyweight
Number of subjects: 0
Study 33039291 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous immunoglobulin (IgPro20) 0.4 g/kg bodyweight
Number of subjects: 0
Study 33039291 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33852121 — intervention group
Group type: COMPARATOR
Intervention: Capecitabine and Lapatinib
Number of subjects: 68
Study 33852121 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine, Lapatinib, and Cituxumumab
Number of subjects: 68
Study 35761129 — intervention group
Group type: EXPERIMENTAL
Intervention: Survivorship care planning (SCP) intervention (one-session with written SCP and follow-up telephone call)
Number of subjects: 89
Study 35761129 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 89
Study 34512358 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 0
Study 34512358 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe
Number of subjects: 0
Study 32693563 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling intervention (COL) - cold-water ingestion, electric fan, ice-filled damp towel
Number of subjects: 8
Study 32693563 — intervention group
Group type: COMPARATOR
Intervention: No cooling (CON)
Number of subjects: 8
Study 35422766 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 g/d of whey protein hydrolysate
Number of subjects: 64
Study 35422766 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin with high (30 g/d) or low (10 g/d) dietary fiber intake
Number of subjects: 64
Study 33899634 — intervention group
Group type: EXPERIMENTAL
Intervention: MTD loaded solid lipid nanoparticles (SLNs) vaginal emulgel
Number of subjects: 0
Study 33899634 — intervention group
Group type: COMPARATOR
Intervention: Marketed vaginal gel (Metron®)
Number of subjects: 0
Study 34789067 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing integrated with Cognitive Behavioral Therapy (MI-CBT)
Number of subjects: 0
Study 34789067 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy alone (CBT-alone)
Number of subjects: 0
Study 33812809 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient navigation by a trained, lay postpartum navigator
Number of subjects: 0
Study 36307514 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated tobacco products
Number of subjects: 89
Study 36307514 — intervention group
Group type: COMPARATOR
Intervention: Combustible cigarettes (CC)
Number of subjects: 89
Study 36307514 — intervention group
Group type: EXPERIMENTAL
Intervention: Stopped smoking (SS)
Number of subjects: 89
Study 34325923 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsular tension ring (CTR) insertion before trifocal IOL implantation
Number of subjects: 86
Study 34325923 — intervention group
Group type: COMPARATOR
Intervention: No capsular tension ring (CTR) insertion (Control group A)
Number of subjects: 86
Study 33119121 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR) for 90 minutes per week for eight sessions
Number of subjects: 39
Study 33119121 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 39
Study 35456295 — intervention group
Group type: EXPERIMENTAL
Intervention: Paste-type Acellular Dermal Matrix (ADM)
Number of subjects: 86
Study 35456295 — intervention group
Group type: COMPARATOR
Intervention: Standard wound care
Number of subjects: 86
Study 32175985 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadratus lumborum block type 2 (QLB)
Number of subjects: 101
Study 32175985 — intervention group
Group type: COMPARATOR
Intervention: Transversus abdominis plane block (TAPB)
Number of subjects: 101
Study 35274710 — intervention group
Group type: EXPERIMENTAL
Intervention: SOC + IO (mFOLFOX6 + Bevacizumab + Avelumab + CEA-targeted vaccine)
Number of subjects: 26
Study 35274710 — intervention group
Group type: COMPARATOR
Intervention: SOC (mFOLFOX6 + Bevacizumab)
Number of subjects: 26
Study 35968060 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine
Number of subjects: 60
Study 35968060 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol
Number of subjects: 60
Study 35968060 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic
Number of subjects: 60
Study 32244205 — intervention group
Group type: EXPERIMENTAL
Intervention: CRASH risk score provided to doctors
Number of subjects: 28
Study 32244205 — intervention group
Group type: COMPARATOR
Intervention: Control group (doctors without CRASH risk score)
Number of subjects: 28
Study 32244205 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery as the best next step
Number of subjects: 28
Study 32244205 — intervention group
Group type: EXPERIMENTAL
Intervention: CRASH risk score for 14-day mortality
Number of subjects: 28
Study 32244205 — intervention group
Group type: EXPERIMENTAL
Intervention: CRASH risk score for unfavorable outcome at 6 months
Number of subjects: 28
Study 35351701 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted hypothermia (34°C-35°C)
Number of subjects: 516
Study 35351701 — intervention group
Group type: COMPARATOR
Intervention: Normothermia (36.5°C-37.5°C)
Number of subjects: 516
Study 33799307 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel oral nutritional supplement (whey and casein protein, ursolic acid, free branch‐chained amino acids, vitamin D) for 12 weeks
Number of subjects: 82
Study 33799307 — intervention group
Group type: COMPARATOR
Intervention: Standard oral nutritional supplement for 12 weeks
Number of subjects: 82
Study 32527972 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular thrombectomy (EVT)
Number of subjects: 380
Study 35377332 — intervention group
Group type: EXPERIMENTAL
Intervention: SFSW parent training intervention (internet-based and telephone-assisted)
Number of subjects: 832
Study 33990376 — intervention group
Group type: EXPERIMENTAL
Intervention: DD-focused OnTrack group
Number of subjects: 301
Study 33990376 — intervention group
Group type: COMPARATOR
Intervention: education‐oriented KnowIt group
Number of subjects: 301
Study 35316705 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 123
Study 35316705 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 123
Study 35316705 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 123
Study 32749930 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaching model of communication skills for oncologists
Number of subjects: 0
Study 34929591 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% Luteolin (LT) for 2 min
Number of subjects: 0
Study 34929591 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4% Galangin (GL) for 2 min
Number of subjects: 0
Study 34929591 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% Proanthocyanidin (PAC) for 2 min
Number of subjects: 0
Study 34929591 — intervention group
Group type: COMPARATOR
Intervention: Phosphoric acid (PA) or ethylenediaminetetraacetic acid (EDTA) for demineralization
Number of subjects: 0
Study 32289864 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model for VTE
Number of subjects: 1359880
Study 34429364 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg rhTNK-tPA (to a maximum of 40 mg)
Number of subjects: 236
Study 34429364 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg rhTNK-tPA (to a maximum of 40 mg)
Number of subjects: 236
Study 34429364 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.32 mg/kg rhTNK-tPA (to a maximum of 40 mg)
Number of subjects: 236
Study 34429364 — intervention group
Group type: COMPARATOR
Intervention: 0.9 mg/kg rt-PA (to a maximum of 90 mg)
Number of subjects: 236
Study 33647734 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure management (SBP target <140 mmHg)
Number of subjects: 2792
Study 33647734 — intervention group
Group type: COMPARATOR
Intervention: Guideline-recommended blood pressure management (SBP target <180 mmHg)
Number of subjects: 2792
Study 33647734 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (elevated body temperature <37.5 vs. ≥37.5 °C)
Number of subjects: 2792
Study 32556055 — intervention group
Group type: EXPERIMENTAL
Intervention: Technique without the use of an interference screw (group A)
Number of subjects: 23
Study 32556055 — intervention group
Group type: COMPARATOR
Intervention: Technique with the use of an interference screw (group B)
Number of subjects: 23
Study 32556055 — intervention group
Group type: COMPARATOR
Intervention: Comparison between group A and group B
Number of subjects: 23
Study 35152879 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning methods for predicting death prognosis
Number of subjects: 246
Study 34254658 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg intrathecal meperidine
Number of subjects: 60
Study 34254658 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg intrathecal meperidine
Number of subjects: 60
Study 34254658 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg intrathecal meperidine
Number of subjects: 60
Study 34254658 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 mg intrathecal meperidine
Number of subjects: 60
Study 34147830 — intervention group
Group type: EXPERIMENTAL
Intervention: Health care delivery structures focusing on mental illness identification
Number of subjects: 37
Study 34147830 — intervention group
Group type: EXPERIMENTAL
Intervention: Health assessment screening on arrival to the short-term custodial setting
Number of subjects: 37
Study 32665394 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive ACP Program (includes clinician communication skills training and patient video decision aids)
Number of subjects: 11000
Study 36038368 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific Carbohydrate Diet (SCD)
Number of subjects: 100
Study 36038368 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean Diet (MD)
Number of subjects: 100
Study 34923962 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (Content learning, reflection and experiential practice)
Number of subjects: 528
Study 34923962 — intervention group
Group type: COMPARATOR
Intervention: Group A (Content learning)
Number of subjects: 528
Study 34923962 — intervention group
Group type: COMPARATOR
Intervention: Group B (Content learning and reflection)
Number of subjects: 528
Study 34590418 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct restorations (DRs) using light-cured composite (GrandioSO, VOCO)
Number of subjects: 30
Study 34590418 — intervention group
Group type: COMPARATOR
Intervention: Indirect restorations (IRs) using precured composite block (Grandio Blocs, VOCO)
Number of subjects: 30
Study 32054897 — intervention group
Group type: EXPERIMENTAL
Intervention: GradientBoosting model
Number of subjects: 999
Study 32054897 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic model
Number of subjects: 999
Study 32054897 — intervention group
Group type: EXPERIMENTAL
Intervention: gbm model
Number of subjects: 999
Study 34715522 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher cf-PWV in males
Number of subjects: 80
Study 34715522 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher cf-PWV in females
Number of subjects: 80
Study 33383570 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbohydrate diet (MAX = 10 g/kg body mass CHO daily)
Number of subjects: 20
Study 33383570 — intervention group
Group type: COMPARATOR
Intervention: Moderate carbohydrate control diet (CON = 6 g/kg body mass CHO daily)
Number of subjects: 20
Study 33383570 — intervention group
Group type: COMPARATOR
Intervention: Moderate carbohydrate control diet (CON)
Number of subjects: 20
Study 33383570 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbohydrate diet (MAX)
Number of subjects: 20
Study 32947920 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclical Ketogenic Reduction Diet (CKD)
Number of subjects: 25
Study 32947920 — intervention group
Group type: COMPARATOR
Intervention: Nutritionally Balanced Reduction Diet (RD)
Number of subjects: 25
Study 35325871 — intervention group
Group type: EXPERIMENTAL
Intervention: Argentine tango dance intervention (90 minutes, twice a week for 12 weeks)
Number of subjects: 36
Study 35325871 — intervention group
Group type: COMPARATOR
Intervention: Control group (continued regular activities)
Number of subjects: 36
Study 33822469 — intervention group
Group type: EXPERIMENTAL
Intervention: SAR425899 (0.12, 0.16 or 0.20 mg)
Number of subjects: 70
Study 33822469 — intervention group
Group type: EXPERIMENTAL
Intervention: liraglutide (1.80 mg)
Number of subjects: 70